Background: The influence of acute cerebral ischemic lesions (CILs) on the revascularization outcome of symptomatic carotid stenosis has been scarcely investigated in the literature. This study evaluated the effect of CILs and their volume on the results of carotid revascularization in symptomatic patients.
carotid revascularization is the potential increase of postoperative complications in some subgroups of patients.
The recent review by De Rango et al 4 showed that rather than the timing of revascularization, the type of preoperative symptomsdtransient ischemic attack (TIA) vs strokedcould influence the postoperative incidence of complications. Carotid revascularization performed #2 weeks after a TIA was associated with a postoperative complication rate as low as 1.6%, whereas patients who underwent revascularization after a stroke encountered a significantly higher risk of major complications (5.0%). Possible causes for this difference are the presence of an ischemic penumbra or an impaired cerebrovascular reactivity after the stroke, with enlargement of the ischemic area or its hemorrhagic transformation after revascularization. 5, 6 However, although the influence of clinical presentation has been well investigated in the literature, data on the effect of the size of the lesions seen at cerebral computed tomography (CT) are sparse. A CT scan is generally performed at the time of symptoms and after 24 to 48 hours in the clinical setting, but current guidelines do not address specifically the correlation among type and size of the acute cerebral ischemic lesion (CIL), timing of revascularization, and outcome.
The aim of present study was therefore to investigate the influence of preoperative CILs and their volume on carotid revascularization outcome.
METHODS
This study was performed according to the rules of the University of Bologna Ethical Review Board.
Study design and setting. Data for consecutive symptomatic patients who underwent carotid revascularization by endarterectomy (CEA) or carotid artery stenting (CAS) from January 2005 to December 2014 in a single academic center were prospectively entered into a dedicated database and reviewed. All patients gave their informed consent for the procedure.
The study end point was to compare the perioperative (30-day) stroke and death rates in patients with and without CIL who underwent carotid revascularization, according to type (CEA vs CAS) and timing (#2 weeks and >2 weeks) of revascularization and to evaluate the effect of CIL volume on the postoperative outcome.
Patients. Carotid revascularization was performed for symptomatic carotid artery stenosis >50% (according to the North American Symptomatic Carotid Endarterectomy Trial Collaborators criteria) fulfilling the requirements of Society for Vascular Surgery guidelines. 1, 7 Clinical characteristics, technical aspects, and perioperative (30-day) outcome were entered into a dedicated database. The clinical characteristics included age, sex, hypertension (systolic blood pressure >140 mm Hg or diastolic >90 mm Hg, or specific therapy), dyslipidemia (total cholesterol >200 mg/dL or low-density lipoprotein >120 mg/dL, or specific therapy), diabetes mellitus (prediagnosed in therapy with oral hypoglycemic drugs or with insulin), current smoking, coronary artery disease (defined as a history of angina pectoris, myocardial infarction or coronary revascularization), chronic obstructive pulmonary disease (defined as chronic bronchitis or emphysema), chronic renal failure (glomerular filtration rate <60 mL/min), contralateral carotid occlusion, and atrial fibrillation (paroxysmal or permanent). Perioperative medical therapy was also considered: specifically, therapy with one or two antiplatelet medications, statins, and oral anticoagulant therapy.
All patients had a preoperative cerebral CT scan evaluation at the time of the neurologic event and after 24 to 48 hours before carotid revascularization. A neurologic evaluation was performed before and after the carotid revascularization by an in-hospital neurologist. TIA was defined as temporary focal neurologic deficit with complete resolution #24 hours, and stroke was a focal neurologic deficit maintained for >24 hours. 7 The time elapsed from symptoms and carotid revascularization was determined by logistic issues and the presence of stable neurologic status (crescendo TIA and stroke in evolution were not considered in the present analysis), considering for an expedited revascularization patients with National Institutes of Health Stroke Scale 8 values <15 and stable cardiologic and respiratory clinical condition. In case of a hemorrhagic cerebral infarction, patients were monitored by cerebral CT evaluation, and the carotid revascularization was performed in case of hemorrhagic resolution and neurologic stability.
As previously described, all CEA procedures were performed by trained vascular surgeons, with the patient under general anesthesia, and with routine shunting and Dacron (DuPont, Wilmington, Del) patching. 9, 10 CAS was selected, as previously reported, in patients at high cardiologic or respiratory risk or with a hostile neck if the preoperative CT angiography showed a normal arch anatomy. 11 The 30-day outcome considered was stroke (clinically evaluated by the neurologist) and death.
Cerebral CT evaluation. A cerebral CT scan was routinely performed at the time of symptoms and after 24 to 48 hours before carotid revascularization (multislice, 16-slice, GE Light Speed scanner; General Electric, Milwaukee, Wisc). Acute CIL was defined as an embolic lesion ipsilateral to the carotid target lesion by expert neuroradiologists. 12, 13 The CIL volume was obtained retrospectively through multiplanar reconstructions, considering the three longer axes in the axial, coronal, and sagittal planes (example in Fig 1) and calculating the volume of the corresponding ellipsoid expressed in mm 3 .
Statistical analysis. Continuous variables are expressed as means 6 standard deviations and frequencies by percentages. Analyses of the differences between two groups were performed using c 2 or Fisher test, when appropriate, for categoric variables. The comparison of the CIL volume between patients with and without postoperative complication was performed by the MannWhitney U test, with data expressed as the median with the interquartile range (IQR). The investigation of CIL volume cutoff was performed by the evaluation of sensitivity and specificity of the receiver operating characteristic (ROC) curve by the Youden J statistic (J ¼ sensitivity þ specificity À 1) to determine the optimal threshold. Multivariable analysis was performed to identify independent risk factors for stroke and stroke/death considering the significant (P < .05) or nearly significant (P < .20) risk factor for stroke and stroke/death at the univariable analysis (data not shown) and reported as the odds ratio (OR) and 95% confidence interval (CI) or with the evaluation of preselected characteristics (age, sex, type of revascularization, timing of revascularization, contralateral carotid occlusion, and selected volume of CIL). A P # .05 (two-tailed) was considered to be significant. The statistical tests were performed using SPSS 21.0 for Windows (IBM Corp, Armonk, NY).
RESULTS
Population characteristics and carotid revascularization outcomes. In a 10-year period, 1800 carotid revascularizations were performed, comprising 1261 CEA (70%) and 539 CAS (30%). Of these, 489 symptomatic patients were considered for the study. Clinical characteristics, medical therapy, and the timing and type of revascularization are reported in Table I Overall, 4 deaths (0.8%) occurred at 30 days, 2 (1.5%) after CEA performed #2 weeks (1 patient death occurred after a postoperative stroke, and 1 died of sudden cardiac arrest), 1 (0.5%) after CEA performed >2 weeks, and 1 (1.9%) after CAS #2 weeks (both died of sudden cardiac arrest).
As reported in Table II , stroke and stroke/death rates were not statistically different in CEA and CAS. The overall stroke and stroke/death rates in the entire population were 4.0% (n ¼ 20)dnone hemorrhagicdand 4.5% (n ¼ 22), respectively. Of the 20 postoperative strokes, 11 (3.3%) occurred after CEA and nine (5.5%) after CAS (P ¼ .27). Characteristics were similar in patients who underwent carotid revascularization #2 weeks or >2 weeks (P > .05, data not shown), and the stroke and stroke/death rates were similar in the two groups (Table II) .
Influence of CIL and volume evaluation. Acute ipsilateral preoperative CIL was identified in 251 of the 489 symptomatic patients (51.4%). As reported Table I , patients with CIL had a higher incidence of diabetes mellitus, contralateral carotid occlusion, and preoperative stroke and more frequently underwent CAS than CEA (66.6% vs 43.7%; P ¼ .001). The presence of an acute CIL was not associated with a significantly higher risk for postoperative stroke (4.8% vs 3.5%; P ¼ .47) or stroke/ death (5.6% vs 3.5%; P ¼ .26). The median value of CIL volume was 1000 mm 3 (IQR, 7000 mm 3 ). As shown in 02; Fig 3) . A postoperative stroke occurred in 12 patients with preoperative CIL. Three (25%) of these patients had a preoperative CIL volume <4000 mm 3 ; in one patient a new cerebral infarction developed after revascularization, and in two patients, no significant modification of the preoperative cerebral imaging was present. Nine patients (75%) had a preoperative CIL volume $4000 mm 3 : 2 had a new ischemic cerebral lesion, 5 had an extension of the preoperative CIL, and 2 showed no substantial modification of the preoperative cerebral imaging. By univariate analysis (Table III) 
DISCUSSION
This study found that patients with stable symptoms who underwent carotid revascularizations had a similar stroke and stroke/death rate when stratified according to the type (CEA vs CAS) and timing (#2 weeks vs >2 weeks) of revascularization. By CT, the overall rate of ipsilateral CIL in the study group was 51%, as a reflection of the type of symptomsdmainly TIAsdwith no significant effect on the outcome of stroke and stroke/death. The presence of CIL was significantly more frequent in patients with diabetes mellitus and contralateral carotid occlusion, probably as an expression of the adjunctive effect small-vessel disease or exhausted cerebral reserve. The literature on the influence of CIL on carotid revascularization outcome is discordant. In their analysis of 503 symptomatic patients, Cao et al 14 found, similarly to our study, an incidence of CIL in patients with stroke of 54% and TIA of 33%. Stroke and death in their series were significantly higher in patients with CIL; however, their study considered both ipsilateral and contralateral lesions. Blohme et al 15 showed that the presence of an ipsilateral CIL was associated with a higher risk of stroke/death compared with patients with no CIL (10% vs 3%; P ¼ .01) in their retrospective analysis of 273 symptomatic patients. Both studies are therefore in contrast with our series and with the data from the European Carotid Surgery Trial (ECST) reported by Bond et al. 16, 17 In fact, data from ECST showed a similar risk of stroke/death in patients with and without CIL (7.5% vs 6.7%; P ¼ .45) in 1604 symptomatic patients who underwent CEA in whom a preoperative cerebral CT was available. A reasonable explanation for such contradictory results might be found in the different effect of CILs on the outcome of cerebral revascularization according to their extension. For that reason, we analysed the CIL volume through a multiplanar cerebral CT evaluation. The median volume of CIL was 1000 mm 3 , and patients who sustained a postoperative stroke had a higher CIL volume than those without complications (5000 mm 3 vs 1000 mm 3 ; P ¼ .01).
By ROC curve analysis, a cutoff CIL volume of 4000 mm 3 was identified as a significant value for postoperative stroke (9% vs 2%; P ¼ .01) with a sensitivity of ) as a predictive risk factor for postoperative stroke. By the Youden J statistic, the best cutoff value was 4000 mm 3 . Area (95% confidence interval [CI]). 75% and specificity of 63%. The multivariate analysis confirmed that a CIL volume of $4000 mm 3 is an independent predictor for postoperative stroke regardless of technique and timing of revascularization, age, sex, contralateral carotid occlusion, and diabetes. Many retrospective studies have analyzed the influence of the clinical characteristics, such as TIA and stroke, on carotid revascularization outcome 18, 19 ; however, one must consider that a significant number of patients with TIA (30%-40%) may present with a CIL and that many patients with a minor stroke (50%) do not have any CIL visible at CT, as shown also in our study. 14 In fact, 18.9% of patients with clinical stroke did not present a CIL at CT, which was instead present in 43% of patients with clinical TIA. Consequently, the evaluation of the type of symptoms is not sufficient to define the extension of brain damage. Some authors considered the National Institutes of Health Stroke Scale as a reliable preoperative evaluation, suggesting that carotid revascularization should be performed only when its value is <15 or 10, with no direct evaluation of the cerebral damage. 20 This method omits patients with TIA who have a visible CIL, however.
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The extension of the cerebral lesion could be a determinant variable for explaining the discordant results obtained after early carotid revascularization in different series. As an example, Rantner et al 21 and Strömberg et al 22 reported a similar postoperative stroke rate of w10% in their series of patients operated on #2 weeks from stroke, in contrast with the postoperative stroke rates of 0% published by Ballotta et al 23 and 2.5% by Paty et al. 24 None of these studies reported the extension of the brain lesions, which can be the reason for such a difference. In our study, patients with a CIL volume $4000 mm 3 had a postoperative stroke rate of 9%, which was significantly higher than the 2% of patients with CIL <4000 mm 3 .
The CIL volume evaluation can be considered an adjunctive element in the assessment of TIA and stroke, which allows the real extent of the cerebral infarction to be objectively quantified and stratification of the risk of carotid revascularization. A variety of systems are proposed for predicting recurrent events, such as the ABCD2 (Age $60 years; Blood pressure $140/90 mm Hg at initial evaluation; Clinical features of the TIA; Duration of symptoms, and Diabetes mellitus) or ABCD3I (Age, Blood Pressure, Clinical Features, Duration, and Diabetes plus Dual TIA) scores, because the identification of patients at higher risk for carotid revascularization would be an important adjunctive tool to ascertain the risk-to-benefit ratio of carotid intervention in symptomatic patients; however, further studies are needed to define objective parameters. 25 Our study has some limitations. Its retrospective design can affect the data interpretation and also influences the sample of the analysis: with a hypothetical preevaluation of 6% of stroke and death rate for symptomatic patients to reach a clinical significance (with an a error of 5% and a b error of 20%), we can postulate a 3% event rate in patients without CIL and 9% in CIL patients. According to present hypothetical values, the sample size necessary to reach a statistical significance is of 550 patients, which is not too far from our sample of 485. The size of the study group affects also the analysis of patients according to the CIL volume (of <4000 mm 3 or >4000 mm 3 , with a not exposed-toexposed ratio of 2:1), because for a 9% vs 2% stroke rate the ideal sample size should be 300 to 350 cases, which is not too far from the 251 cases of the present study. Next, a more homogeneous group of patients in type and timing of carotid revascularization, would be needed to increase the accuracy of the multivariate analysis. Moreover, patients with crescendo TIA and stroke in evolution were not analyzed because the cerebral CT has a low accuracy and a high false-negative rate in these patients who undergo emergency operations. Also, an analysis of revascularization results in the very early period (ie, #2 days from symptoms) was not performed because of the low number of patients.
The use of cerebral CT scan in the evaluation of CIL reflects our common clinical practice. Magnetic resonance imaging has a higher sensitivity than CT in detecting CIL; however, it can also identify temporary lesions that disappear #1 month and are difficult to interpret. 26 
CONCLUSIONS
The simple presence of CILs is not a predictor for postoperative complications after carotid revascularization, but their extension can influence the outcome. Specifically, if the CIL volume is $4000 mm 3 , the risk of postoperative stroke is increased independently from other variables such as timing and type of revascularization. Commonly, the threshold for risk stratification of carotid revascularization is set at one-third extension of the middle cerebral artery territory; however, this value is subjective and difficult to measure precisely. 27 Our method for volume measurement can be considered as a more objective evaluation of the extension of the CIL. The evaluation of the CIL extension can therefore be considered a useful tool to stratify the operative risk of symptomatic carotid stenosis. 
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